Teva Pharmaceutical Industries Ltd. (TEVA) stock tumbled Friday afternoon as Wall Street came down hard on the company. The stock closed at $20.60.
Credit Suisse analyst Vamil Divan downgraded the Israeli pharmaceutical company to “neutral” from “outperform.”
